Re:Excision's CRISPR HIV therapy is heading into human testi...
by catdog on Sunday September 19, 2021 @02:51AM
(#28582243)
Agree it seems likely that dosing plays a fundamental role.
Moderna while still seeming to suffer from this problem seems to be suffering less than Biontech, they are very similar in general, biggest difference is Moderna having already a longer minimum waiting period between the shots and a way bigger dose of mRNA per shot. So this may already be a hint.
Also currently it looks like a third shot is giving a really great boost compared to the second one, at least in the short term. Same with using mRNA as a booster shot after a vector based vaccine.
Moderna while still seeming to suffer from this problem seems to be suffering less than Biontech, they are very similar in general, biggest difference is Moderna having already a longer minimum waiting period between the shots and a way bigger dose of mRNA per shot. So this may already be a hint.
Also currently it looks like a third shot is giving a really great boost compared to the second one, at least in the short term. Same with using mRNA as a booster shot after a vector based vaccine.